[15 October 2013]
Products Affected - Description
Tubersol, Sanofi Pasteur
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 49281-0752-21)
5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 49281-0752-22)
Reason for the Shortage
- Sanofi Pasteur states the shortage is due to production delays
- JHP states the shortage was due to increased demand for the product.
Aplisol, JHP Pharmaceuticals
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 42023-0104-01)
5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 42023-0104-05)
Estimated Resupply Dates
- Sanofi Pasteur has Tubersol 5 mL vials on back order and the company cannot estimate a release date. Tubersol 1 mL vials are being allocated and the company estimates additional product will be available in early-October 2013.
- JHP is allocating all Aplisol presentations at this time.
October 15, 2013; September 16, 2013; July 29, 2013; June 3, 2013; May 15, 2013; April 12, 2013; April 1, 2013; March 7, 2013; January 24, 2013; December 10 2012; November 14, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins